Wedmont Private Capital Acquires 4,295 Shares of Colgate-Palmolive (NYSE:CL)

Wedmont Private Capital increased its stake in shares of Colgate-Palmolive (NYSE:CL) by 53.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,391 shares of the company’s stock after acquiring an additional 4,295 shares during the quarter. Wedmont Private Capital’s holdings in Colgate-Palmolive were worth $1,070,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive during the third quarter valued at about $53,000. Prospera Private Wealth LLC acquired a new position in Colgate-Palmolive in the 3rd quarter valued at approximately $64,000. True Wealth Design LLC lifted its position in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after acquiring an additional 672 shares during the period. Finally, Continuum Advisory LLC grew its holdings in shares of Colgate-Palmolive by 93.4% during the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after purchasing an additional 368 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $87.02 on Tuesday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm has a market cap of $71.10 billion, a P/E ratio of 24.93, a P/E/G ratio of 3.31 and a beta of 0.44. The firm has a 50 day simple moving average of $92.49 and a 200 day simple moving average of $97.98. Colgate-Palmolive has a fifty-two week low of $79.69 and a fifty-two week high of $109.30.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.30%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Analysts Set New Price Targets

CL has been the subject of several research reports. Piper Sandler reduced their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. TD Cowen dropped their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price objective for the company from $105.00 to $101.00 in a report on Monday, October 28th. Finally, JPMorgan Chase & Co. upped their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and a consensus price target of $103.63.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.